Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
JMIR Mhealth and Uhealth|July 30, 2025
Minimal Clinically Important Difference of Average Daily Steps Measured Through a Consumer Smartwatch in People With Mild-to-Moderate Parkinson Disease: Cross-Sectional StudyEdoardo Bianchini, Marika Alborghetti, Silvia Galli, et al.
Journal of Personalized Medicine|January 26, 2024
Lateral Pectoral Nerve Identification through Ultrasound-Guided Methylene Blue Injection during Selective Peripheral Neurectomy for Shoulder Spasticity: Proposal for a New ProcedurePaolo Zerbinati, Jonathan Bemporad, Andrea Massimiani, et al.
JMIR Formative Research|March 18, 2025
Reliability of Average Daily Steps Measured Through a Consumer Smartwatch in Parkinson Disease Phenotypes, Stages, and Severities: Cross-Sectional StudyEdoardo Bianchini, Domiziana Rinaldi, Lanfranco De Carolis, et al.
Parkinsonism & Related Disorders|March 18, 2023
The impact of dysphagia in Parkinson's disease patients treated with levodopa/carbidopa intestinal gelDomiziana Rinaldi, Gabriele Imbalzano, Silvia Galli, et al.
Frontiers in Neurology|June 30, 2026
L-Dopa/Carbidopa intestinal gel infusion in advanced Parkinson's disease: real-life mobility insights from wearable sensorsAlessandro Zampogna, Luigi Borzì, Domiziana Rinaldi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 10, 2025
A comprehensive guide to digital neurology. An update on current development on digital neurology derived from the Digital Neuro Hub projectFrancesco Iodice, Luca Cuffaro, Michele Romoli, et al.
Journal of Neurology|December 12, 2024
Spasticity patterns assessment and recognition for therapeutic approaches (SPARTA) in multiple sclerosis: a multicenter epidemiological studyPaolo De Blasiis, Andrea Massimiani, Cristina Inglese, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 14, 2026
Treatment stability comparison among different ADD-ON therapies in fluctuating Parkinson's disease patients: the role of clinical and demographic factorsDomiziana Rinaldi, Silvia Galli, Gabriele Imbalzano, et al.
Frontiers in Neuroscience|February 9, 2026
Comparative effect of vortioxetine and sertraline on clinical and inflammatory profile in Parkinson's disease with comorbid depressionMarika Alborghetti, Camilla Moliterni, Edoardo Bianchini, et al.
Current Neuropharmacology|April 8, 2025
The Potential Influence of Associated Antidepressants on the Pharmacokinetic Profile of Esketamine in Patients Affected by Treatment-resistant DepressionMarika Alborghetti, Luana Lionetto, Ginevra Lombardozzi, et al.
Pageof 5